系统性红斑狼:关于病变发生,诊断,预防和治疗的最新见解
Xiaofeng Dai1, Yuting Fan2,3, Xing Zhao4
1National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Shaanxi Provincial Center for Regenerative Medicine and Surgical Engineering, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, P. R. China. xiaodai@xjtufh.edu.cn.
Signal transduction and targeted therapy
|March 18, 2025
概括
系统性红斑狼 (SLE) 是一种复杂的自身免疫性疾病. 本综述确定了SLE病变的关键机制,并提出了针对免疫衰减,细胞因子平衡和碎片清除的创新治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 系统性红斑狼 (SLE) 是一种慢性,多器官的自身免疫性疾病,具有不同的临床表现.
- 目前的SLE治疗方法差异很大,有些药物可以矛盾地诱导或加剧这种情况.
- 了解SLE的发病过程对于开发更安全,更有效的疗法至关重要.
研究的目的:
- 审查驱动SLE病变的机制.
- 为了对目前的SLE诊断方法和预防策略进行分类.
- 根据它们的作用机制,全面分析现有的SLE治疗方法.
主要方法:
- 关于SLE病变发生,诊断,预防和治疗的文献综述.
- 根据机制对SLE决定因素进行分类.
- 对遗传,表观遗传,激素和环境因素的分析.
- 根据功能机制对治疗剂的分类.
主要成果:
- 确定了SLE发病和进展的三个关键机制:免疫系统减弱,细胞因子微环境稳定性恢复和受损的碎片清理机械救援.
- 详细介绍了SLE治疗的复杂性,包括非目标效应和潜在的疾病诱导.
- 提供了SLE诊断的最新概述,包括发病,活动和并发症.
结论:
- 提出了对SLE管理至关重要的三个核心机制.
- 强调需要针对特定SLE途径的创新治疗策略.
- 强调了通过更深入地了解疾病机制和向治疗来改善SLE患者治疗结果的潜力.
更多相关视频
相关概念视频
Autoimmune Disorders
366
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
366
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Hypersensitivities
468
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
468
Inflammatory Bowel Disease IV: Pharmacological Management
83
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
83
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
T Cell Types and Functions
730
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
730


